Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.

Kulkarni PS, Kawade A, Kohli S, Munshi R, Maliye C, Gogtay NJ, S RH, Singh K, Vengadakrishnan K, Panigrahi SK, Sahoo J, Bavdekar A, Garg BS, Raut A, Raj JP, Saxena U, Chaudhari VL, Patil R, Venkatarao E, Kumari N, Surendran J, Parulekar V, Gagnon L, Gensale T, Dharmadhikari A, Gairola S, Kale S, Pisal SS, Dhere RM, Mallya A, Poonawalla CS, Kapse D

Open source

DOI
10.1016/s1473-3099(24)00576-0
Published
2025 Apr
Container
The Lancet. Infectious diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-24-00576-0,
  title = {Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.},
  author = {Kulkarni PS and Kawade A and Kohli S and Munshi R and Maliye C and Gogtay NJ and S RH and Singh K and Vengadakrishnan K and Panigrahi SK and Sahoo J and Bavdekar A and Garg BS and Raut A and Raj JP and Saxena U and Chaudhari VL and Patil R and Venkatarao E and Kumari N and Surendran J and Parulekar V and Gagnon L and Gensale T and Dharmadhikari A and Gairola S and Kale S and Pisal SS and Dhere RM and Mallya A and Poonawalla CS and Kapse D},
  year = {2025},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(24)00576-0},
  url = {https://doi.org/10.1016/s1473-3099(24)00576-0}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.
AU  - Kulkarni PS
AU  - Kawade A
AU  - Kohli S
AU  - Munshi R
AU  - Maliye C
AU  - Gogtay NJ
AU  - S RH
AU  - Singh K
AU  - Vengadakrishnan K
AU  - Panigrahi SK
AU  - Sahoo J
AU  - Bavdekar A
AU  - Garg BS
AU  - Raut A
AU  - Raj JP
AU  - Saxena U
AU  - Chaudhari VL
AU  - Patil R
AU  - Venkatarao E
AU  - Kumari N
AU  - Surendran J
AU  - Parulekar V
AU  - Gagnon L
AU  - Gensale T
AU  - Dharmadhikari A
AU  - Gairola S
AU  - Kale S
AU  - Pisal SS
AU  - Dhere RM
AU  - Mallya A
AU  - Poonawalla CS
AU  - Kapse D
PY  - 2025
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(24)00576-0
UR  - https://doi.org/10.1016/s1473-3099(24)00576-0
ER  - 

APA

PS, K., A, K., S, K., R, M., C, M., NJ, G., RH, S., K, S., K, V., SK, P., J, S., A, B., BS, G., A, R., JP, R., U, S., VL, C., R, P., E, V., N, K., J, S., V, P., L, G., T, G., A, D., S, G., S, K., SS, P., RM, D., A, M., CS, P., & D, K. (2025). Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(24)00576-0

Source records